Kauss; Valerjans

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kauss; Valerjans.The latest application filed is for "method of preparing neramexane or a salt thereof".

Company Profile

0.12.23

Kauss; Valerjans - Riga N/A LV
Kauss; Valerjans - Rigariga LV

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of preparing Neramexane or a salt thereof Grant 8,692,021 - Gold , et al. April 8, 2	2014-04-08
Glycine B antagonist Grant 8,288,549 - Henrich , et al. October 16, 2	2012-10-16
Method Of Preparing Neramexane Or A Salt Thereof App 20120245391 - Gold; Markus-Rene ; et al.	2012-09-27
Glycine B Antagonists App 20120220577 - Henrich; Markus ; et al.	2012-08-30
Metabotropic Glutamate Receptor Modulators App 20120178742 - Henrich; Markus ; et al.	2012-07-12
Pyrazolopyrimidines for treating CNS disorders App 20110212956 - Danysz; Wojciech ; et al.	2011-09-01
Glycine B Antagonist App 20110190342 - Henrich; Markus ; et al.	2011-08-04
Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators Grant 7,985,753 - Danysz , et al. July 26, 2	2011-07-26
Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulators Grant 7,947,689 - Danysz , et al. May 24, 2	2011-05-24
Pyrazolopyrimidines, A Process For Their Preparation And Their Use As Medicine App 20110003820 - Henrich; Markus ; et al.	2011-01-06
1-Amino-alkyl-cyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists App 20100298442 - Parsons; Christopher Graham Raphael ; et al.	2010-11-25
Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors Grant 7,598,384 - Jirgensons , et al. October 6, 2	2009-10-06
Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors App 20090227582 - Kauss; Valerjans ; et al.	2009-09-10
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors Grant 7,550,482 - Kauss , et al. June 23, 2	2009-06-23
Pyrazolopyrimidines, a process for their preparation and their use as medicine App 20080039476 - Danysz; Wojciech ; et al.	2008-02-14
Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine App 20080039458 - Danysz; Wojciech ; et al.	2008-02-14
Pyrazolopyrimidines, a process for their preparation and their use as medicine App 20080032998 - Danysz; Wojciech ; et al.	2008-02-07
Metabotropic glutamate receptor modulators App 20070299113 - Kalvinsh; Ivars ; et al.	2007-12-27
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists App 20070185151 - Parsons; Christopher Graham Raphael ; et al.	2007-08-09
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT.sub.3, and neuronal nicotinic receptor antagonists Grant 7,238,703 - Parsons , et al. July 3, 2	2007-07-03
1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists App 20070105961 - Parsons; Christopher Graham Raphael ; et al.	2007-05-10
Cyclic and acyclic propenones for treating CNS disorders App 20060074083 - Kalvinsh; Ivars ; et al.	2006-04-06
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists Grant 7,022,729 - Parsons , et al. April 4, 2	2006-04-04
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists App 20060019983 - Parsons; Christopher Graham Raphael ; et al.	2006-01-26
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists App 20060019982 - Parsons; Christopher Graham Raphael ; et al.	2006-01-26
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors App 20060004001 - Jirgensons; Aigars ; et al.	2006-01-05
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors App 20050288284 - Jirgensons, Aigars ; et al.	2005-12-29
Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors App 20050197361 - Jirgensons, Aigars ; et al.	2005-09-08
Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists Grant 6,828,462 - Henrich , et al. December 7, 2	2004-12-07
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists App 20040034055 - Parsons, Christopher Graham Raphael ; et al.	2004-02-19
Novel melanocortin receptor agonists and antagonists App 20030195212 - Lundstedt, Torbjorn ; et al.	2003-10-16
Unsaturated 1-Amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists App 20030166634 - Henrich, Markus ; et al.	2003-09-04
1-Amino-alkylcyclohexanes as trypanocidal agents Grant 6,602,862 - Kelly , et al. August 5, 2	2003-08-05
1-Amino-alkylcyclohexane NMDA receptor antagonists Grant 6,034,134 - Gold , et al. March 7, 2	2000-03-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.